(Inter)national Boards/Committees/Memberships

• Dutch Pediatric Association (NVK), since 1991 (member)

• Dutch Society of Oncology, NVvO, 1993- onwards (member)

• Dutch Hematology Association (NVvH), since 1995 (member)

• International Society of Pediatric Oncology (SIOP), since 1996 (member)

• European Hematology Association (EHA), since 1998 (member)

• American Society of Hematology (ASH), since 1998 (member)

• EWOG-MDS group 1999-onwards (member)

• Dutch Childhood Oncology Group (DCOG) Renal tumor committee 2000 – 2008 (member), 2008 – onwards (chair)

• I-BFM-AML committee, 2000-onwards (member)

• DCOG MDS protocol committee, 2003-onwards (chair)

• Scientific Board of EWOG MDS, 2005 – 2011 (member), 2011 – 2017 (chair)

• Steering committee DCOG-LATER committee, 2006 – onwards (member)

• Advisory Board of the International JMML Foundation, 2007- onwards (member)

• DCOG Disease Committee Bone Marrow Failure and MDS, 2008-onwards (member)

• SIOP Scientific Programs Advisory Committee(SPAC), 2008-onwards (contributor)

• DCOG Steering committee for Late effects, 2009- onwards (member)

• Steering CIE SIOP-RTSG, since 2009 (member)

• Advisory Board of the DCOG (Raad van Toezicht), 2014 – onwards (member)

• Organizing committee of annual meeting of the European Hematology Association(EHA), SPC 2014, 2015, 2016 (member)

• International Steering Committee for renal tumors (SIOP RTSG), 2014- onwards (member and co-chair)

• Scientific EHA symposium board (SPC) 2014-2017 (member)

• SIOP scientific CIE, October 2017-2020 (member)

• Member SIOP-e (member)

• PanCare (member)

Editorial Board

• European J of Cancer

• Pediatric Blood and cancer

• Journal of Pediatric Endocrinology

Reviewer

• Pediatric Blood and Cancer

• Haematologica

• J of Pediatric Biochemistry

• Clinical Cancer Research

• Leukaemia Research

• J Ped Hem Onc

• Clin Cancer Research

• Leukaemia

• British J of Hematology

• J of supportive care in Cancer

• European J of Endocrinology

• Cancer

• Am J of Blood

• Eur J of Cancer

• Lancet Oncology

• BMC

• JCO

.

MD, PhD Professor translational Pediatric Oncology.

Since 2015, working in the Princess Maxima Center for Pediatric Oncology, and responsible for the now established centralized care and translational research program for all children with renal tumors and on the identification of (genetic) determinants direct and late toxicity.
Since 2016 Medical director of the late effects clinics in the Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Research
Decidated to translational research in pediatric oncology, with a special focus on myeloid malignancies, renal tumors and the (genetic) variation of early and late toxicity of childhood cancer.